DNMT3AR882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell FrequencyThomas Köhnke, Ravindra Majeti, Daiki Karigane et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 3
Highly efficient in vivo hematopoietic stem cell transduction using an optimized self-complementary adeno-associated virusCarsten T. Charlesworth, Hiromitsu Nakauchi, Tze-Kai Tan et al.|Molecular Therapy — Methods & Clinical Development|2025Cited by 3